Clinical Trial

Liposome Bupivacaine Interscalene Total Shoulder

Study Description

Liposome Bupivacaine Interscalene Total Shoulder

This is a randomized prospective outcomes study comparing two groups of patients. One group will receive liposomal bupivacaine plus bupivacaine and the other will receive bupivacaine alone in interscalene blocks when undergoing total shoulder arthroplasty. The purpose of the study is to determine if LB plus bupivacaine provides superior pain control compared to bupivacaine alone when injected in an interscalene block for patients undergoing total shoulder arthroplasty surgery.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - liposome bupivacaine

interscalene block with liposomal bupivacaine plus bupivacaine

Drug - Bupivacaine

interscalene block with bupivacaine

Additional Information

Official Study Title

Prospective Randomized Controlled Trial Comparing Liposomal Bupivacaine to Bupivacaine Interscalene Blocks for Total Shoulder Arthroplasty Surgery; a Pilot Study

Clinical Trial ID

NCT03587636

ParticipAid ID

en557d